Sen. Lee Floats Bill To Drop Biosimilar Hurdle

By Kelly Lienhard (November 18, 2022, 4:23 PM EST) -- A new U.S. Senate bill looks to reduce barriers to the introduction of cheaper generic counterparts for expensive brand-name biologic drugs by eliminating the need for so-called "switching studies," which examine the risks of using the treatments interchangeably. ...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!